G371-0167 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-{2-ethoxy-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-4-yl}acetamide

G371-0167 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-{2-ethoxy-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-4-yl}acetamide
G371-0167 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-2-{2-ethoxy-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-4-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G371-0167
N-(2H-1,3-benzodioxol-5-yl)-2-{2-ethoxy-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-4-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G371-0167

Molecular Formula

C18H16N4O5 (C18 H16 N4 O5)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-2-{2-ethoxy-3-oxo-3H,4H-pyrido[2,3-b]pyrazin-4-yl}acetamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-2-{2-ethoxy-3-oxo-3H4H-pyrido[23-b]pyrazin-4-yl}acetamide

SMILES

CCOC1=Nc2cccnc2N(CC(Nc(cc2)cc3c2OCO3)=O)C1=O

InChI

InChI=1S/C18H16N4O5/c1-2-25-17-18(24)22(16-12(21-17)4-3-7-19-16)9-15(23)20-11-5-6-13-14(8-11)27-10-26-13/h3-8H,2,9-10H2,1H3,(H,20,23)

InChI Key

BDWOSKMNGHGQHA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15005091

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

368.35

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.751

Distribution Coefficient, logD

1.751

Water Solubility, LogSw

-2.35

Polar Surface Area

82.197

Acid Dissociation Constant (pKa)

11.46

Base Dissociation Constant (pKb)

1.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.20

G371-0167 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G371-0167 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G371-0167?
Check Price and Availability of G371-0167, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G371-0167 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G371-0167
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G371-0167
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G371-0167 available by request